Yumanity Therapeutics Management
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Richard Peters (59 yo)
Dr. Richard Peters, M.D., Ph D., is a Founder at X4 Pharmaceuticals, Inc. He serves as Independent Director at Aprea Therapeutics AB since July 2020. He served as Director of PIC Therapeutics Inc. He Co-Fo...
CEO Compensation Analysis
|Richard Peters's Compensation vs Yumanity Therapeutics Earnings|
|Date||Total Comp.||Salary||Company Earnings|
|Jun 30 2022||n/a||n/a|
|Mar 31 2022||n/a||n/a|
|Dec 31 2021||US$4m||US$618k|
Compensation vs Market: Richard's total compensation ($USD4.49M) is above average for companies of similar size in the US market ($USD770.27K).
Compensation vs Earnings: Insufficient data to compare Richard's compensation with company performance.
Experienced Management: YMTX's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Experienced Board: YMTX's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.